SCHEDULE 13G/A: Conestoga Capital Advisors and Funds Disclose Significant Passive Stake in LeMaitre Vascular, Holding Over 8% Combined

Conestoga Capital Advisors and its affiliated funds have filed an updated Schedule 13G, disclosing a combined beneficial ownership of 8.12% and 5.4% respectively, in LeMaitre Vascular Inc.'s common stock as of December 31, 2024.

Summary

• Conestoga Capital Advisors reported beneficial ownership of 1,825,724 shares of LeMaitre Vascular Inc. common stock, representing 8.12% of the class.
• Conestoga Capital Advisors holds sole voting power over 1,692,833 shares and sole dispositive power over 1,825,724 shares.
• CONESTOGA FUNDS reported beneficial ownership of 1,213,518 shares of LeMaitre Vascular Inc. common stock, representing 5.4% of the class.
• CONESTOGA FUNDS holds sole voting power over 1,213,521 shares and sole dispositive power over 1,213,521 shares.
• Both entities are based in Delaware and operate from Wayne, Pennsylvania.
• The filing is an Amendment No. 8, indicating an update to previously reported ownership.
• The securities are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 6

Explanation: The sentiment is moderately positive as it indicates significant institutional investment in the company, suggesting confidence from a professional asset manager. However, it's a passive filing, so it doesn't convey active support or new strategic initiatives.

Positives

• Significant institutional ownership by Conestoga Capital Advisors and CONESTOGA FUNDS, indicating confidence from a professional investment firm.
• The passive nature of the investment (Schedule 13G filing) suggests a long-term, non-activist stance, which can provide stability.

Risks

• As a passive investment, Conestoga Capital Advisors and CONESTOGA FUNDS do not intend to influence the control of LeMaitre Vascular Inc., meaning their significant stake may not lead to direct strategic changes or governance improvements.

Future Outlook

The document does not contain any forward-looking statements or guidance from the issuer or the reporting persons regarding future financial performance or strategic direction.

Industry Context

The filing indicates continued institutional interest in the medical device sector, specifically in companies like LeMaitre Vascular Inc., which specializes in vascular devices. Such filings are common for investment advisors and funds that hold significant, passive stakes in publicly traded companies within their investment mandates.

Stakeholder Impact

• Shareholders: The disclosure of significant institutional ownership may be viewed positively, potentially increasing investor confidence and liquidity.
• Company Management: Awareness of a large, passive institutional holder may influence management's focus on long-term value creation, though without direct engagement from the investor.

Key Dates

Keywords

LeMaitre Vascular Inc., Conestoga Capital Advisors, CONESTOGA FUNDS, Schedule 13G, Beneficial Ownership, Common Stock, Institutional Investor, Medical Devices, Vascular, SEC Filing